Pre-market Hot Trades in US Stocks

Quantum Computing is up 9.90% in pre-market trading. Based on recent key news:

1. On May 22, Benzinga reported that Quantum Computing Inc.'s stock has a positive short-term and medium-term trend, while the long-term trend remains negative. The stock is currently trading about 84% above its 52-week low, indicating investor confidence in its short-term performance;

2. On May 21, the Trump administration announced plans to invest $2 billion in nine quantum computing companies to solidify the United States' leading position in the field of quantum computing. This move could drive up the stock prices of related companies, with Quantum Computing benefiting from the market's attention to quantum technology;

3. On May 21, French President Macron announced an additional investment of €1 billion in the quantum strategy sector, further promoting the development of the quantum computing industry. Such international investment plans may enhance market confidence in quantum computing companies and boost stock prices. The investment boom in the quantum computing industry has garnered high market attention.

Zenta is up 7.88% in pre-market trading, with no significant recent news. The trading is active, and the capital flow is evident. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation.

Top Gainers in Pre-market US Stocks

PicoCELA is up 174.24% in pre-market trading, with no significant recent news. The trading is active, and the capital flow is evident. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation.

Akari Therapeutics is up 99.23% in pre-market trading. Based on recent key news:

1. On May 21, Akari Therapeutics announced the completion of a $5 million private placement, driving the stock price up. The company plans to use the raised funds for working capital and general corporate purposes, resulting in a significant increase in stock price.

2. On May 22, Akari implemented a 1-for-40 reverse stock split, causing the stock price to rise 105.58% in pre-market trading. This move aims to increase the stock price and improve market liquidity.

3. On May 22, Akari's ADC drug combined with KRAS inhibitors showed a synergistic effect, enhancing cytotoxicity against KRAS-driven cancer models, boosting market confidence in its R&D prospects. The biotechnology industry has been quite volatile recently and requires attention.

Leifras is up 94.12% in pre-market trading. Based on recent key news:

1. On May 21, Leifras announced the acquisition of 100% of Donghai Sports. This move aims to expand market share and increase customer lifetime value, with the transaction expected to be completed by June 1. This news significantly boosted Leifras' stock price. Source: Reuters

2. On May 21, Leifras plans to introduce a digital management system at Donghai Sports. This move will enhance operational efficiency and customer experience, further strengthening market competitiveness Source: Reuters The Japanese sports education market is active in mergers and acquisitions